Nancy R. Phelan

CIK: 0001750316

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ACHV

ACHIEVE LIFE SCIENCES, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

ACHV
ACHIEVE LIFE SCIENCES, INC.
Jul 27, 2026
Award(A)
Stock Option (right to buy)
Direct
25K shares-
ACHV
ACHIEVE LIFE SCIENCES, INC.
Jul 27, 2026
Award(A)
Restricted Stock Unit (RSU)
Direct
16.7K shares-
ACHV
ACHIEVE LIFE SCIENCES, INC.
Jun 6, 2025
Award(A)
Stock Option (right to buy)
Direct
31.5K shares-
ACHV
ACHIEVE LIFE SCIENCES, INC.
Jan 13, 2025
Award(A)
Stock Option (right to buy)
Direct
47.3K shares-

		Type	Shares	Price		Ownership
Jul 27, 2026	ACHV ACHIEVE LIFE SCIENCES, INC.	Award(A) Stock Option (right to buy)	25,000	-	-	Direct
Jul 27, 2026	ACHV ACHIEVE LIFE SCIENCES, INC.	Award(A) Restricted Stock Unit (RSU)	16,700	-	-	Direct
Jun 6, 2025	ACHV ACHIEVE LIFE SCIENCES, INC.	Award(A) Stock Option (right to buy)	31,500	-	-	Direct
Jan 13, 2025	ACHV ACHIEVE LIFE SCIENCES, INC.	Award(A) Stock Option (right to buy)	47,250	-	-	Direct

1-4 of 4 transactions

About Phelan Nancy R.

Phelan Nancy R. (SEC CIK 0001750316) files insider reports with the SEC as Director of ACHIEVE LIFE SCIENCES, INC. (ACHV).

Signal8 holds 4 ownership filings by Phelan Nancy R. (1 Form 3, 3 Form 4), filed between Jan 14, 2025 and Jul 29, 2026. Those filings report 4 transactions, from Jan 13, 2025 to Jul 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Phelan Nancy R.'s filings is in BOTHELL, WA.

Recent filings by Phelan Nancy R.

Jul 27, 2026: Grants or awards of ACHV derivative securities (2 lines, Form 4, code A).
Jun 6, 2025: Grant or award of ACHV derivative securities (Form 4, code A).
Jan 13, 2025: Grant or award of ACHV derivative securities (Form 4, code A).

Other insiders filing for ACHIEVE LIFE SCIENCES, INC. (ACHV)

Halladay Benjamin, Chief Financial Officer
Stewart Richard Alistair, Director
Sellig Thomas, Director
Martin Christopher Nathan, Director
Royston Aaron, Director
Waldman Reid Alexander, Director

How to read Form 4 transaction codes